Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $180,471 - $386,333
-5,068 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $18,361 - $26,330
-319 Reduced 5.92%
5,068 $354,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $1.03 Million - $1.43 Million
-14,209 Reduced 72.51%
5,387 $419,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $400,575 - $550,657
4,439 Added 29.29%
19,596 $1.87 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $15,547 - $23,118
166 Added 1.11%
15,157 $1.88 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $25,179 - $33,482
216 Added 1.46%
14,991 $1.98 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $41,935 - $59,832
421 Added 2.93%
14,775 $1.96 Million
Q3 2020

Nov 16, 2020

BUY
$72.92 - $102.01 $62,638 - $87,626
859 Added 6.37%
14,354 $1.46 Million
Q2 2020

Aug 05, 2020

BUY
$55.75 - $92.75 $752,346 - $1.25 Million
13,495 New
13,495 $1.17 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Shepherd Financial Partners LLC Portfolio

Follow Shepherd Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Financial Partners LLC with notifications on news.